Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice

D. H. Gutmann, E. Winkeler, O. Kabbarah, N. Hedrick, S. Dudley, P. J. Goodfellow, Robert (Mike) Liskay

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Defects in DNA mismatch repair (MMR) have been implicated in the genesis of a diverse set of human cancers. Recent studies have suggested that one of the targets of MMR is the neurofibromatosis 1 (NF1) gene. To evaluate the contribution of Mlh1 MMR deficiency to Nf1 tumorigenesis, Mlh1-/-; Nf1+/- mice were generated. All Mlh1-/-;Nf1+/- mice (n = 21) were dead by 260 days compared to none of the Nf1+/- mice. In all, 50% of the Mlh1-/-;Nf1+/- mice were dead at 150 days compared to 252 days for Mlh1-/- mice. Nine of the Mlh1-/-;Nf1+/- mice were found to harbor intrathoracic NOS2-immunoreactive myeloid leukemias similar to the hematopoietic malignancies observed in older Nf1+/- mice. As expected, significant microsatellite instability was observed in six of six tumors and neurofibromin expression was lost in all tumors analysed. These results suggest that MMR deficiency can accelerate myeloid leukemogenesis in Nf1+/- mice, presumably by inactivating Nf1 gene expression.

Original languageEnglish (US)
Pages (from-to)4581-4585
Number of pages5
JournalOncogene
Volume22
Issue number29
DOIs
StatePublished - Jul 17 2003

Fingerprint

Neurofibromatosis 1
Neurofibromatosis 1 Genes
DNA Mismatch Repair
Neurofibromin 1
Neoplasms
Microsatellite Instability
Myeloid Leukemia
Hematologic Neoplasms
Carcinogenesis
Gene Expression

Keywords

  • Leukemia
  • Mismatch repair
  • Neurofibromin
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Gutmann, D. H., Winkeler, E., Kabbarah, O., Hedrick, N., Dudley, S., Goodfellow, P. J., & Liskay, R. M. (2003). Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene, 22(29), 4581-4585. https://doi.org/10.1038/sj.onc.1206768

Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. / Gutmann, D. H.; Winkeler, E.; Kabbarah, O.; Hedrick, N.; Dudley, S.; Goodfellow, P. J.; Liskay, Robert (Mike).

In: Oncogene, Vol. 22, No. 29, 17.07.2003, p. 4581-4585.

Research output: Contribution to journalArticle

Gutmann, DH, Winkeler, E, Kabbarah, O, Hedrick, N, Dudley, S, Goodfellow, PJ & Liskay, RM 2003, 'Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice', Oncogene, vol. 22, no. 29, pp. 4581-4585. https://doi.org/10.1038/sj.onc.1206768
Gutmann DH, Winkeler E, Kabbarah O, Hedrick N, Dudley S, Goodfellow PJ et al. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene. 2003 Jul 17;22(29):4581-4585. https://doi.org/10.1038/sj.onc.1206768
Gutmann, D. H. ; Winkeler, E. ; Kabbarah, O. ; Hedrick, N. ; Dudley, S. ; Goodfellow, P. J. ; Liskay, Robert (Mike). / Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. In: Oncogene. 2003 ; Vol. 22, No. 29. pp. 4581-4585.
@article{00aad8eb63484d2db7e430f9a550a5c6,
title = "Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice",
abstract = "Defects in DNA mismatch repair (MMR) have been implicated in the genesis of a diverse set of human cancers. Recent studies have suggested that one of the targets of MMR is the neurofibromatosis 1 (NF1) gene. To evaluate the contribution of Mlh1 MMR deficiency to Nf1 tumorigenesis, Mlh1-/-; Nf1+/- mice were generated. All Mlh1-/-;Nf1+/- mice (n = 21) were dead by 260 days compared to none of the Nf1+/- mice. In all, 50{\%} of the Mlh1-/-;Nf1+/- mice were dead at 150 days compared to 252 days for Mlh1-/- mice. Nine of the Mlh1-/-;Nf1+/- mice were found to harbor intrathoracic NOS2-immunoreactive myeloid leukemias similar to the hematopoietic malignancies observed in older Nf1+/- mice. As expected, significant microsatellite instability was observed in six of six tumors and neurofibromin expression was lost in all tumors analysed. These results suggest that MMR deficiency can accelerate myeloid leukemogenesis in Nf1+/- mice, presumably by inactivating Nf1 gene expression.",
keywords = "Leukemia, Mismatch repair, Neurofibromin, Tumor suppressor gene",
author = "Gutmann, {D. H.} and E. Winkeler and O. Kabbarah and N. Hedrick and S. Dudley and Goodfellow, {P. J.} and Liskay, {Robert (Mike)}",
year = "2003",
month = "7",
day = "17",
doi = "10.1038/sj.onc.1206768",
language = "English (US)",
volume = "22",
pages = "4581--4585",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "29",

}

TY - JOUR

T1 - Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice

AU - Gutmann, D. H.

AU - Winkeler, E.

AU - Kabbarah, O.

AU - Hedrick, N.

AU - Dudley, S.

AU - Goodfellow, P. J.

AU - Liskay, Robert (Mike)

PY - 2003/7/17

Y1 - 2003/7/17

N2 - Defects in DNA mismatch repair (MMR) have been implicated in the genesis of a diverse set of human cancers. Recent studies have suggested that one of the targets of MMR is the neurofibromatosis 1 (NF1) gene. To evaluate the contribution of Mlh1 MMR deficiency to Nf1 tumorigenesis, Mlh1-/-; Nf1+/- mice were generated. All Mlh1-/-;Nf1+/- mice (n = 21) were dead by 260 days compared to none of the Nf1+/- mice. In all, 50% of the Mlh1-/-;Nf1+/- mice were dead at 150 days compared to 252 days for Mlh1-/- mice. Nine of the Mlh1-/-;Nf1+/- mice were found to harbor intrathoracic NOS2-immunoreactive myeloid leukemias similar to the hematopoietic malignancies observed in older Nf1+/- mice. As expected, significant microsatellite instability was observed in six of six tumors and neurofibromin expression was lost in all tumors analysed. These results suggest that MMR deficiency can accelerate myeloid leukemogenesis in Nf1+/- mice, presumably by inactivating Nf1 gene expression.

AB - Defects in DNA mismatch repair (MMR) have been implicated in the genesis of a diverse set of human cancers. Recent studies have suggested that one of the targets of MMR is the neurofibromatosis 1 (NF1) gene. To evaluate the contribution of Mlh1 MMR deficiency to Nf1 tumorigenesis, Mlh1-/-; Nf1+/- mice were generated. All Mlh1-/-;Nf1+/- mice (n = 21) were dead by 260 days compared to none of the Nf1+/- mice. In all, 50% of the Mlh1-/-;Nf1+/- mice were dead at 150 days compared to 252 days for Mlh1-/- mice. Nine of the Mlh1-/-;Nf1+/- mice were found to harbor intrathoracic NOS2-immunoreactive myeloid leukemias similar to the hematopoietic malignancies observed in older Nf1+/- mice. As expected, significant microsatellite instability was observed in six of six tumors and neurofibromin expression was lost in all tumors analysed. These results suggest that MMR deficiency can accelerate myeloid leukemogenesis in Nf1+/- mice, presumably by inactivating Nf1 gene expression.

KW - Leukemia

KW - Mismatch repair

KW - Neurofibromin

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0041667820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041667820&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206768

DO - 10.1038/sj.onc.1206768

M3 - Article

C2 - 12881715

AN - SCOPUS:0041667820

VL - 22

SP - 4581

EP - 4585

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 29

ER -